© 2023 MJH Life Sciences™ and Nutritional Outlook. All rights reserved.
Clinical trials show that consumption of Cavamax W6 can contribute to the reduction of the blood glucose rise that occurs after starch-containing meals.
Wacker offers a soluble dietary fiber that is scientifically proven and acknowledged by EFSA to have a significant effect on reducing postprandial glycaemic response. This fiber, branded under the trademark Cavamax W6, is an alpha-cyclodextrin, a carbohydrate enzymatically derived from starch. Clinical trials show that consumption of Cavamax W6 can contribute to the reduction of the blood glucose rise that occurs after starch-containing meals. Further clinical trials show a positive effect of Cavamax W6 on blood lipid levels. Cavamax W6 is highly stable in heat and acidic conditions, is non-hygroscopic and non-browning, and is ideally suited for beverage applications.
Booth C46